Coriolis Successfully Completes FDA Inspection Without Observations

This outcome reinforces confidence in the quality systems supporting our clients’ projects and in the reliability of our GMP operations. It reflects our continued commitment to consistently applying established quality standards across our work.

From early development through commercialization, we support biopharmaceutical development programs with formulation expertise and analytical services under R&D and GMP conditions. Our quality systems provide a robust framework for generating reliable data and maintaining the documentation needed to advance our clients’ programs.

We remain committed to supporting global development and commercialization programs with scientific rigor and a strong focus on quality. Thank you to our teams whose dedication and commitment contributed to this achievement.